Biography

Prof. Solomon Ike Okosun

Georgia State University, USA


E-mail: iokosun@gsu.edu


Qualifications

1998 Post Doctoral Fellow, Loyola University, Stritch School of Medicine, Preventive Medicine & Epidemiology

1996 Ph.D., Epidemiology, The University of Pittsburgh, Graduate School of Public Health

1987 M.S.(Public Health), Biostatistics & Epidemiology, College of Public Health, The University of Oklahoma Health Sciences Center

1984 M.S., Microbiology, Alabama A & M University, School of Arts and Sciences Normal

1978 B.S., Bacteriology, North Dakota State University, College of Science and Mathematics


Publications (Selected)

  1. Okosun, I. S. (2025). Elevated uric acid level and metabolic syndrome in Non-Hispanic Black American adults. Journal of Diabetes & Metabolic Disorders, 24(1), 1-9.
  2. Amuda, O., Okosun, B. O., Abdi, H., & Okosun, I. S. (2024). Prevalence and secular trends in premetabolic syndrome in the United States: Findings from 1999-2020 nationally representative data of adults. Annals of epidemiology, 93, 10-18.
  3. Nkemjika, S., Tokede, O., Okosun, I. S., Jadotte, Y., & Pigott, T. (2023). Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: a systematic review and meta-analysis. Cancer Epidemiology, 86, 102409.
  4. Nkemjika, S., Tumenta, T., Salazar, L., & Okosun, I. S. (2023). Waiting times disparities for medication-assisted therapy among opioid use disorder treatment population in the United States. Journal of addictive diseases, 41(4), 322-333.
  5. Shaikh, N., Dennis, K., Brown, J., Airhihenbuwa, C., & Okosun, I. (2022). Protocol for the Development of Culturally-Tailored mHealth Messages for a Diabetes Prevention Program (DPP) in New Immigrants in the US: A Pilot Study. Current Developments in Nutrition, 6, 1158.
  6. Nkemjika, S., Oforeh, K., Brown, C., Olayinka, O., & Okosun, I. S. (2023). Sociodemographic attributes and racial disparities for waiting times towards admissions for substance use disorder treatment in the tri-state area (NY-NJ-CT): a cross-sectional study. International Journal of Mental Health and Addiction, 21(5), 2892-2922.
  7. Nkemjika, S., Olatunji, E., Olwit, C., Jegede, O., Brown, C., Olupona, T., & Okosun, I. S. (2022). Comorbid Substance Use and Mental Health disorders: Prior Treatment/Admission as a predictor of criminal arrest among American youths. Cureus, 14(1).
  8. Nkemjika, S., Olayinka, O., Atolagbe, A., Begum, G., Perera, P., Oladeji, O., ... & Olupona, T. (2022). Traumatic brain Injury related schizophrenia in individuals without family history: A case series. Journal of the National Medical Association, 114(2), 207-210.
  9. Tetteh, A. K., Yankey, B. A., & Okosun, I. S. (2021). Cardiovascular disease risk and key anthropometrics: a trend analysis. British Journal of Cardiac Nursing, 16(11), 1-16.
  10. Brown, C., Nkemjika, S., Yankey, B., Okosun, I., & Okosun, I. S. (2021). Alternative tobacco product use and smoking quit attempts among teenagers in the United States: a cross-sectional study. Cureus, 13(7).
  11. Nkemjika, S., Tokede, O., Jadotte, Y., Olatunji, E., Bosah, J., Pigott, T., & Okosun, I. S. (2021). Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: a systematic review protocol. JBI evidence synthesis, 19(12), 3355-3362.
  12. Okosun, I. S., Airhihenbuwa, C., & Henry, T. L. (2021). Allostatic load, metabolic syndrome and self-rated health in overweight/obese Non-Hispanic White, non-Hispanic Black and Mexican American adults. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(4), 102154.
  13. Vellozzi-Averhoff, C., Thompson, W. W., Vellozzi, C., Okosun, I., Kinlaw, K., & Bussey-Jones, J. (2021). Disparities in communication among the inpatient homeless population at a safety-net hospital. Journal of the National Medical Association, 113(4), 440-448.
  14. Suvada, K., Plantinga, L., Vaughan, C. P., Markland, A. D., Mirk, A., Burgio, K. L., ... & Johnson 2nd, T. M. (2020). Comorbidities, age, and polypharmacy limit the use by US older adults with nocturia of the only FDA-approved drugs for the symptom. Clinical therapeutics, 42(12), e259-e274.
  15. Airhihenbuwa, C. O., Iwelunmor, J., Munodawafa, D., Ford, C. L., Oni, T., Agyemang, C., ... & Okosun, I. (2020). Culture matters in communicating the global response to COVID-19. Preventing chronic disease, 17, E60.


Profile Details

WoS ResearcherID: AAR-3008-2020

https://publichealth.gsu.edu/profile/ike-okosun/

https://www.researchgate.net/profile/Ike-Okosun

Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top